PDA

View Full Version : General Cancer News

Pages : 1 2 3 4 5 6 7 8 9 10 11 [12] 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51
  1. Radiation scans cause increased scrutiny
  2. ExonHit Therapeutics, Genmab A/S sign agreement for selection of novel splice variant
  3. 2,300 researchers under one roof at American Society of Echocardiography 21st Annual
  4. Xoft reports clinical benefits of isotope-free electronic radiation therapy for treat
  5. Medicare coverage of unproven mammography screening device leads to surge in usage
  6. NBC's TODAY Show to focus on PF in an interview with a patient from California
  7. Women who drink boiled coffee at lower risk of breast cancer
  8. CombiMatrix Diagnostics receives final licensure documentation and approvals to begin
  9. ARBs may be linked with increased risk of developing cancer: US scientists
  10. Cancer overtreatment raises concern; Physicians tend to use new technology even befor
  11. Study aims at determining optimal dose of nab-paclitaxel with carboplatin as first-li
  12. Exercise helps patients recover shoulder movement after breast cancer surgery
  13. AVEO granted patents for tests to identify cancer patients likely to respond to tivoz
  14. Report reveals increase in patients influence on success, failure of new drugs
  15. Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Deci
  16. Merck Serono, EMD Serono resume Stimuvax clinical program for NSCLC
  17. Stimuvax clinical program resumed in patients with NSCLC
  18. Pan-Canadian Cancer Research Strategy to maximize impact of cancer research funding
  19. TechniScan launches clinical study of Warm Bath Ultrasound system in Rochester
  20. OncoMed, Bayer Schering Pharma to develop and commercialize novel anti-cancer stem ce
  21. Bayer, OncoMed collaborate to develop anti-cancer stem cell therapeutics to target Wn
  22. Early detection helps prevent nearly thousand deaths from breast cancer each year: Re
  23. Nineteen facilities named Centers of Excellence in APBI for use of SAVI applicator
  24. Hey heyy asdasdpoowerwer scvxcv zxcv543444
  25. Encouraging interim results from stem and regenerative cell-enriched fat grafting bre
  26. Expression of BCRP in RA patients may indicate higher disease activity, predict resis
  27. FVL gene mutation increases risk of blood clots in breast cancer patients treated wit
  28. BioSante announces presentation of LibiGel safety update at ENDO 2010
  29. Naviscan announces presentations on PEM technology at Society of Nuclear Medicine Ann
  30. New phase I/IIa clinical trial of AR-42 for blood cancer at OSUCCC-James
  31. Prototype drug blocks MCL-1 protein that helps tumors survive treatment: Scientists
  32. Consumers can now access high quality health and medical information on Internet usin
  33. EIN News expands health news-monitoring coverage
  34. ZIOPHARM Oncology announces guidance on palifosfamide Phase III trial in metastatic s
  35. Dako, Omnyx partner to develop clinical algorithms for digital pathology
  36. Independent DMC recommends continuation of BioSante's ongoing LibiGel CV and Breast C
  37. Al Amal Hospital in Qatar commences treatment with Varian's RapidArc radiotherapy
  38. Aurora Dedicated Breast MRI System installed at Ruijin Hospital, China
  39. Cancer forms “intolerable burden” on the community: Health Minister
  40. Recent objections would eliminate use of routine breast cancer screening mammograms:
  41. Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO
  42. Toshiba announces availability of Aegis breast imaging workstation with MR products
  43. UK cancer survival rates increase at 3% each year
  44. Researchers find way to get beneficial effects of estrogen without increasing woman's
  45. U.S. District Court Judge approves amended settlement in WTC litigation
  46. UCSD School of Medicine receives $5.3M grant to study effect of weight loss in breast
  47. Hoag Hospital launches IORT program for breast cancer treatment
  48. AVEO receives EMA orphan medicinal product designation for tivozanib
  49. Blood flow disturbances in artery determine appearance of atherosclerosis: Study
  50. Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovo
  51. Fixing the Broken Model: Look Inside Your Company
  52. PARP inhibitors may be effective in men with prostate cancer due to BRCA2 alteration:
  53. HHS Secretary to speak about how Affordable Care Act will benefit women
  54. CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets
  55. Research roundup: Docs' views of industry gifts; Chemotherapy payments; Health law an
  56. Transposons create genomic instability and are implicated in cancer and other disease
  57. Zila introduces angled exam mirror as part of ViziLite Plus oral lesion identificatio
  58. Health reform law this week: Some states to miss deadline on high-risk pools, tanning
  59. Teva announces FDA approval, commercial launch of generic ARIMIDEX
  60. APP Pharmaceuticals to distribute Anastrozole tablets in the U.S. market
  61. Bicycling and brisk walking associated with less weight gain in obese, premenopausal
  62. Young breast cancer patients more likely to discontinue hormone therapy
  63. Mylan Pharmaceuticals receives FDA final approval for Anastrozole Tablets ANDA
  64. New test to predict DCIS spares unnecessary radiotherapy
  65. Celgene signs definitive merger agreement to acquire Abraxis BioScience
  66. Cutting drug prices hampers new development
  67. Key mechanism present in virgin olive oil protects body against breast cancer: Resear
  68. Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS
  69. AstraZeneca announces new support program for patients on ARIMIDEX
  70. IBM, University of Missouri collaborate to develop cloud computing environment for ge
  71. Modified Citrus Pectin holds promise against prostate cancer
  72. Overweight girls less likely to develop breast cancer in later life
  73. ZERO demands ACS apology on effectiveness of PSA test
  74. Cancer Research UK raises £200,000 in Network Rail partnership celebrations
  75. Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study
  76. Novel molecular pathway that regulates invasive growth, metastasis in ER-positive bre
  77. Crux Biomedical commences enrollment in Retrieve 2 pivotal U.S. IDE trial of new Vena
  78. Hologic enters definitive agreement to acquire Sentinelle Medical
  79. Genentech submits BLA for trastuzumab-DM1 in advanced HER2-positive breast cancer
  80. Data on activity of Nektar's NKTR-102 in gastrointestinal cancer presented at ESMO 12
  81. First Edition: July 7, 2010
  82. Invision Sally Jobe introduces SBU technology for early detection of breast cancer
  83. Neoprobe initiates third multi-center Phase 3 clinical study of Lymphoseek
  84. Olaparib shows promising results against inherited forms of breast and ovarian cancer
  85. Heart attack death rates drop in hospitals; CDC reports increase in colon cancer scre
  86. Overall cancer mortality rates continue to decrease, new report shows
  87. FDA-approved bioidentical estrogens help women manage common symptoms of menopause
  88. Clinical performance data of Cervista HPV HR presented at International Papillomaviru
  89. Regular use of fish oil supplements reduces risk of invasive ductal breast cancer
  90. PolyMAC technique retrieves specific proteins needed to study formation of cancer cel
  91. Mathematical model for imaging tumors in breast using microwave tomography
  92. 20% of Canadians less sympathetic towards lung cancer sufferers
  93. ESMO releases enhanced, revised set of clinical guidelines to care for cancer patient
  94. BioCurex reports first set of results supporting RECAF blood test for monitoring canc
  95. Roxane announces FDA approval for Anastrozole Tablets ANDA
  96. Promising study may lead to potential new therapeutics for women facing triple-negati
  97. Males with faulty BRCA2 genes at risk of breast cancer
  98. Data shows potential health benefits of S-equol in relieving menopausal symptoms
  99. Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research
  100. Researchers demonstrate that MSNs can effectively suppress tumors in mice
  101. Two missing genes can develop aggressive form of leukaemia in mice: Research
  102. Midatech, Immunotope form joint venture to develop antigen based products for immune
  103. Manuscript based on study of Clarient InsightDx Mammostrat to be published in Breast
  104. Common SNP in sequence of human genome conferring risk of vascular diseases discovere
  105. Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial
  106. Devicor completes acquisition of Ethicon Endo-Surgery's Breast Care business
  107. OICR, CCO announce $6 million in funding for Health Services Research Program project
  108. IDSI installs CT Laser Mammography system at Tata Memorial Hospital
  109. MD+DI survey names Crux Biomedical as one of "50 Companies to Watch"
  110. New study shows SAVI radiation therapy controls rate of breast cancer
  111. QIAGEN's digene HPV Test improves cervical cancer control: Study
  112. Antigen Express granted patent for AE37 immunotherapeutic vaccine: Generex Biotechnol
  113. Valentus Medical Technologies signs partnership agreement with Medical Tactile for Su
  114. The Samuel Waxman Cancer Research Foundation announces research grants totaling $1.54
  115. New prediction tool calculates risk for recurrence following breast conserving surger
  116. Lung cancer patients likely to suffer significant stigma due to disease's link to smo
  117. New prediction tool estimates risk for recurrence after breast-conserving surgery in
  118. Loyola primary care physicians honored with Blue Ribbon rating from Blue Cross and Bl
  119. Highlights of AAPM 52nd meeting
  120. Specific biomarkers can effectively distinguish breast cancer
  121. Komen Advocacy Alliance applauds new federal rules for no-cost access to mammography
  122. Plexxikon announces promising preclinical data of PLX3397
  123. Premier, Xoft execute group purchasing contract
  124. Scientists discover that C35 gene becomes overactive in HER2 positive tumours
  125. Insurers will pick up preventive care costs under new rules
  126. Arsenic nanoparticle to combat aggressive type of breast cancer prevalent in young wo
  127. VCU Medical Center ranked in 2010-2011 Best Hospitals
  128. Innovative imaging system uses night vision technology to tackle common side effect o
  129. Overview of AAPM annual meeting
  130. Survival rates of nine types of cancer in Spain
  131. Two-thirds of world's population are vitamin D-insufficient or deficient
  132. Agendia to provide testimony on federal regulation of laboratory developed tests
  133. Lab-on-Bead technology helps researchers cut years from drug development
  134. National Trauma Institute launches 'Stop the Bleeding' awareness and giving campaign
  135. NEOP increases shares to 205 milliion
  136. Researchers to receive $1.2M from Susan G. Komen for the Cure for breast cancer resea
  137. Anonymous Email Slams Dendreon Stockholders
  138. Three different methods for accurately measuring breast density
  139. Geron commences enrollment in imetelstat Phase 2 clinical trial for NSCLC
  140. Researchers identify a mechanism that explains different phases of CML progression
  141. New type of gene regulation, DNA behavior in breast cancer cells in response to estro
  142. Case Western Reserve awarded $0.5M for study of breast cancer in older women
  143. ARUP enters partnership to offer deCODE's DNA-based prostate cancer risk assessment t
  144. Researchers discover fundamental process of mitosis offers potential target for pharm
  145. Genentech disappointed with FDA ODAC's recommendation against Avastin
  146. iCAD launches new advanced MRI product suite
  147. Rate of women getting mammography screenings stalls; colorectal cancer screenings rem
  148. ACI challenges study that attempts to link cleaning products to breast cancer
  149. Link between cleaning products and breast cancer not proved
  150. Abbott second-quarter global sales increase 17.8% to $8.8 billion
  151. The waiting game
  152. Avastin – breast cancer drug, fails to pass the FDA advisory panel vote on efficacy
  153. New campaign empowers, inspires women and families affected by epilepsy
  154. Researchers receive $780,000 to study estrogen levels, behavior of breast cancer tumo
  155. Merrimack, sanofi-aventis initiate dosing in MM-121 and exemestane combination Phase
  156. African women risk high for triple negative breast cancer
  157. 2010 Life Beyond Cancer Retreat invites applications
  158. New technique to detect circulating genetically abnormal cells in non- small lung can
  159. Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan
  160. GRB7 gene drives an aggressive form of breast cancer, researchers find
  161. First patient enrolled in Phase 3 SyNAPSe study of BHR-100 for TBI
  162. Axela acquires Xceed Molecular
  163. Today's OpEds: Health reform and long-term care; Health care incentives; Reasons for
  164. Abviva to receive patent for its new Mammastatin technology
  165. Four research teams to study role of exercise in preventing, treating chronic disease
  166. New York Times article highlights potential value of early cancer detection technolog
  167. Cytori Therapeutics receives approval for Celution System
  168. CIHR grants $2.5 million to probe impact of physical activity on breast cancer
  169. NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized
  170. Scientists identify genetic variants for breast cancer
  171. BCL2 marker impacts on chemotherapy to breast cancer patients: Research
  172. Texas raises organ donor registry; D.C. not ready for medical marijuana sales; L.A. h
  173. Clarient second-quarter net revenue increases 21% to $28.7 million
  174. New Zealand MEDSAFE approves ABRAXANE for metastatic breast cancer
  175. BioCurex’s RECAF blood test potential to monitor cancer recurrence, treatment
  176. Researchers discover enzyme crucial for DNA repair
  177. Phenolic compounds in peach, plum kills breast cancer cells
  178. Study links SNP, concentrations of serum creatinine for kidney function
  179. New discovery may lead to effective targeted treatments for prostate cancer: UCLA
  180. Families with male breast cancer perceive as being at higher risk: Study
  181. ZIOPHARM second-quarter net loss from operations increases to $5.1 million
  182. Epigenetic changes of DNA in breast cancer relates to environmental risk factors: Stu
  183. NHS Breast Screening Programme detects 1,200 invasive cancers
  184. COGS receive grant from National Institute of Mental Health to examine about schizoph
  185. Cell-of-origin for prostate cancer identified
  186. Taoist Tai Chi internal arts of health celebrates 40 years
  187. MSU creates mentored program to increase number of researchers in women's health
  188. Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in
  189. OHSU acquires BSD-500 Hyperthermia System
  190. Scientists find different factors contribute to reduced effectiveness of breast scree
  191. Celsion reports net loss of $2.6M for second-quarter 2010
  192. Kohl's, American Cancer Society announces new program to fight against breast cancer
  193. Smoking, nipple piercing shows risk factors for subareolar breast abscess: Research
  194. Celera decreases second-quarter net loss to $6.1 million
  195. Study shows oral contraceptive use increases risk of breast cancer in African America
  196. NCI panel recommends Celsion's Phase III ThermoDox HEAT Study as Priority Clinical Tr
  197. New study of breast cancer survivors may help physicians ease side effect of treatmen
  198. Infinity reports $18.4 million total revenue for second-quarter 2010
  199. Common ancestor of humans, sponges can reveal nature of cancer genetic networks
  200. FDA clears iCAD's VeraLook computer-aided detection product for virtual colonoscopy
  201. HF-WBI effective for patients with early stage breast cancer
  202. ImmunoGen fourth-quarter 2010 net loss increases to $13.4 million
  203. Ferroportin levels are strong predictors of propensity for breast cancer recurrence:
  204. Scientists suggest home genetic tests may cause unnecessary stress
  205. HGC publishes guidelines to protect people using DIY genetic tests
  206. CTI second-quarter total net operating expenses decrease to $20.0 million
  207. Gene associated with susceptibility to chronic pain caused by nerve injury identified
  208. Scientists discover gene linked to eight-fold risk of breast cancer recurrence
  209. Incyte second-quarter total revenues increase to $49.8 million
  210. Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulati
  211. Agendia inaugurates new clinical genomics laboratory
  212. Researchers identify gene associated with susceptibility to chronic pain caused by ne
  213. Hologic announces reimbursing for liquid-based cytology in Norwegian cervical screeni
  214. BCF publishes two new patient publications on Pain Management and Physical Therapy
  215. Oil Can Henry's customers raise $45,401 to support Susan G. Komen for the Cure
  216. ESMO Congress provides forum for presentation of new research on treatment of cancer
  217. GTx second-quarter net loss increases to $12.9 million
  218. Aragon initiates dosing in ARN-509 Phase 1/2 clinical trial for castration-resistant
  219. CytRx reports net income for second-quarter 2010 compared to net loss for previous ye
  220. Health Canada approves first targeted biological therapy to show survival benefit in
  221. Scientist to research on molecular machinery of breast cancer
  222. Study to determine sensitivity of mammography, somo•v in detecting breast cancers
  223. Researcher to investigate ADAM12 gene role in breast cancer
  224. Synta second-quarter net loss increases to $9.1 million
  225. Breath test to detect cancer: Study
  226. Scientists develop nanomachines to release drugs inside living cancer cells
  227. Clarient receives patent for Mammostrat breast cancer prognostic test
  228. Smile Pink campaign encourages women, men to support early breast cancer testing
  229. Progestin types impact on tumor-stage specific effects: Study
  230. Study shows physicians reluctant to use finasteride for prostate cancer
  231. Study finds hormone replacement therapy increases breast cancer risk
  232. GenSpera issued additional patent for G-202
  233. Premier international conference to highlight understanding of cancer disparities
  234. WCRF statistics: Breast cancer rates are higher in the UK
  235. BMI indicates breast cancer risk in women using postmenopausal hormone therapy
  236. K-State researcher receives grant from NIH to continue cancer research
  237. Syndax raises $6 million to support ENCORE 301 study in breast cancer
  238. High rates of screening reduce breast cancer mortality rates in UK
  239. Pathway's drug development milestone triggers $4.5M tranche of Series A private equit
  240. Komen Advocacy Alliance thanks Congress for 6-month extension of enhanced federal fun
  241. Genta reports second-quarter net income of $25.4M against net loss of $43.1M in 2009
  242. Study finds Olaparib can reduce tumor size in ovarian cancer women
  243. CPF urges people to consider clinical trials for pulmonary fibrosis
  244. BioSante second-quarter net loss increases to $10.8 million
  245. Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin
  246. Study finds no link among estrogen and lung cancer mortality in postmenopausal women
  247. Scientists identify genes associated with aggressive breast cancer
  248. Breast pathology experts meeting to update new advances in breast surgery
  249. First Edition: August 16, 2010
  250. FDA considers dropping Avastin approval, approves five-day emergency contraception pi